We are pleased to announce CHI’s Twelfth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The Twelfth Annual High-Content Analysis 2015 meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, high-content screening of 3D models and ultra high-resolution imaging. This year, we will also co-locate CHI’s Inaugural Phenotypic Screening meeting, offering two tracks to choose from, expanded exhibit hall and an offering of user group meetings and dinner courses. The Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically-relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma.
Full time graduate students and PhD Candidates are encouraged to apply for the High-Content Analysis or Phenotypic Screening student fellowship program.
Applications are due by November 14, 2014. Ten fellowship award winners will receive a poster presentation slot and up to $900 savings on their registration fee.
High-Content Analysis meeting:
Phenotypic Drug Discovery
Ultra High-Resolution Imaging
HCA in 3D Cell Models, Tissues and Animal Models
Image Analysis and Data Management
New Biological Models for HCA
High-Content Flow Cytometry
Phenotypic Screening meeting:
Case Studies in Phenotypic Screening
Target/Pathway Identification and Validation
Physiologically-Relevant Models for Phenotypic Screening
Data Analysis for Phenotypic Screening
Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Deadline for submission is Friday, July 25, 2014.
For more details on the conference, please contact:
Executive Director, Conferences
For exhibit & sponsorship information, please contact:
Manager, Business Development